hiPSC-based models to decipher the contribution of human astrocytes to Alzheimer's disease and potential therapeutics
Mol Neurodegener
.
2023 Mar 25;18(1):19.
doi: 10.1186/s13024-023-00612-9.
Authors
Julia Tcw
1
2
3
,
Amaia M Arranz
4
5
Affiliations
1
Department of Pharmacology, Physiology & Biophysics, Boston University, Chobanian & Avedisian School of Medicine, Boston, USA. juliatcw@bu.edu.
2
Graduate Program of Neuroscience, Boston University, Boston, USA. juliatcw@bu.edu.
3
Graduate Program of Bioinformatics, Boston University, Boston, USA. juliatcw@bu.edu.
4
Achucarro Basque Center for Neuroscience, Bilbao, Spain. amaia.arranz@achucarro.org.
5
Ikerbasque Basque Foundation for Science, Bilbao, Spain. amaia.arranz@achucarro.org.
PMID:
36966344
PMCID:
PMC10039591
DOI:
10.1186/s13024-023-00612-9
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
MeSH terms
Alzheimer Disease*
Astrocytes
Humans
Induced Pluripotent Stem Cells*
Grants and funding
K01 AG062683/AG/NIA NIH HHS/United States
AARG-21-850389/ALZ/Alzheimer's Association/United States
U19 AG069701/AG/NIA NIH HHS/United States
1R56AG078733/GF/NIH HHS/United States